Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ADC Therapeutics SA

http://www.adctherapeutics.com/

Latest From ADC Therapeutics SA

ADC-Focused Myricx Moves To Next Phase With £90m Cash Injection

The UK spin-out from Imperial College London and the Francis Crick Institute has secured a significant series A financing to advance its novel antibody-drug conjugates which it believes offers a highly differentiated profile over standard payload classes.

Financing Cancer

Finance Watch: Verona Accesses Up To $650m As Ensifentrine Approval Deadline Nears

Public Company Edition: Verona Pharma arranged up to $400m in new debt and up to $250m in revenue-related financing ahead of its COPD drug launch. Also, Organon, Sobi and Pacira priced $1bn, $275.1m and $250m note sales, respectively. Marinus, Emergent and Ginkgo cut jobs.

Financing Business Strategies

In Competitive DLBCL Setting, Pfizer Goes Old School With Adcetris

The ECHELON-3 trial in third-line diffuse large B-cell lymphoma showed positive topline results regardless of CD30 expression, and the drug maker intends to take the data to the FDA.

Biologics Clinical Trials

Finance Watch: Lexeo Launches 20th US Biopharma IPO In 2023

Public Company Edition: Lexeo raised $100m to advance its genetic medicines. Also, Blue Owl Capital acquired funds managed by Cowen Healthcare Investments, gaining about $1bn in life science assets, BMS priced $4.5bn in notes to fund its Mirati purchase and Viridian raised $185m in a private placement.

Financing Growth
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • ADC Therapeutics Sarl
    • ADC Therapeutics S.A.
UsernamePublicRestriction

Register